Cogent Bioscis Rg
COGT
USD
STOCK MARKET:
NMS
Open
 
...
Large gap with delayed quotes
Last quote
04/27/2026 - 16:33:09
Bid
04/27/2026 - 16:34:28
Bid
Volume 		Ask
04/27/2026 - 16:34:28
Ask
Volume
36.50
-0.31 ( -0.84% )
36.47
100
36.55
200
More information
Analysis by TheScreener
24.04.2026
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 24.04.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 24.04.2026.
Interest
  Weak
Two stars since 21.04.2026.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 21.04.2026 at a price of 36.73.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 24.04.2026.
4wk Rel Perf
  -3.99%
 
The four-week dividend-adjusted underperformance versus SP500 is 3.99%.
Sensibility
  High
The stock has been on the high-sensitivity level since 24.04.2026.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.56%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.48%.
Mkt Cap in $bn
  5.97
With a market capitalization between $2 & $8bn, COGENT BIOSCIENCES is considered a mid-cap stock.
G/PE Ratio
  1.53
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
  47.97
The estimated PE is for the year 2028.
LT Growth
  73.45%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  224
For 1% of index variation, the stock varies on average by 2.24%.
Correlation
  0.17
Stock movements are totally independent of index variations.
Value at Risk
  29.81
The value at risk is estimated at USD 29.81. The risk is therefore 81.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  21.04.2026